Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
|---|---|---|---|---|---|
| C0032580 | Adenomatous Polyposis Coli | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0011570 | Mental Depression | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0027051 | Myocardial Infarction | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0280634 | Adult Acute Monocytic Leukemia | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0543859 | Amyotrophic Lateral Sclerosis, Guam Form | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0009021 | Clonorchiasis | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0014038 | Encephalitis | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0027765 | nervous system disorder | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C1292769 | Precursor B-cell lymphoblastic leukemia | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0022680 | Polycystic Kidney Diseases | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0025500 | Mesothelioma | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C3714636 | Pneumonitis | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
| C0007102 | Malignant tumor of colon | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
| C1306459 | Primary malignant neoplasm | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
| C0699790 | Colon Carcinoma | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
| C0027051 | Myocardial Infarction | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
| C0027651 | Neoplasms | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
| C0013595 | Eczema | PLA2G2E | 30814 | phospholipase A2 group IIE | Q9NZK7 |
| C0024897 | Mastocytoma | PLA2G2E | 30814 | phospholipase A2 group IIE | Q9NZK7 |
| C2242987 | Benign Mastocytoma | PLA2G2E | 30814 | phospholipase A2 group IIE | Q9NZK7 |
| C0028754 | Obesity | PLA2G2E | 30814 | phospholipase A2 group IIE | Q9NZK7 |
| C0334664 | Mast Cell Neoplasm | PLA2G2E | 30814 | phospholipase A2 group IIE | Q9NZK7 |
| C0011615 | Dermatitis, Atopic | PLA2G2E | 30814 | phospholipase A2 group IIE | Q9NZK7 |
| C0006142 | Malignant neoplasm of breast | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
| C1956346 | Coronary Artery Disease | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
